Finance

Lists
LYB:NYSE
Lyondellbasell Industries N.v
USD 61,17
+1,93%
(+1,16) 1D
USD 61,62
+0,74% (+0,45)
Pre-market
Closed: 14 Okt., 16:00:08 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LYB...
Open
USD 60,26
High
USD 61,28
Low
USD 60,16
Mkt. cap
19,76 mjd
Avg. vol.
3,53 m
Volume
950,00
Dividend
4,51%
Quarterly dividend
USD 0,69
Ex-dividend date
24 Aug. 2026
52-wk high
USD 83,94
52-wk low
USD 41,58
EPS
-USD 1,11
Beta
0,26
Shares outstanding
323,04 m
No. of employees
19 k
Open
USD 60,26
High
USD 61,28
Low
USD 60,16
Mkt. cap
19,76 mjd
Avg. vol.
3,53 m
Volume
950,00
Dividend
4,51%
Quarterly dividend
USD 0,69
Ex-dividend date
24 Aug. 2026
52-wk high
USD 83,94
52-wk low
USD 41,58
EPS
-USD 1,11
Beta
0,26
Shares outstanding
323,04 m
No. of employees
19 k
News stories
From web sources and news partners
Profile
LyondellBasell Industries N.V. is an American multinational chemical company, incorporated in the Netherlands with U.S. operations headquartered in Houston, Texas and offices in London, UK. The company is the largest licensor of polyethylene and polypropylene technologies. It also produces ethylene, propylene, polyolefins, and oxyfuels. LyondellBasell was formed in December 2007 by the acquisition of Lyondell Chemical Company by Basell Polyolefins for $12.7 billion. As of 2016, Lyondell was the third largest independent chemical manufacturer in the United States. LyondellBasell's global headquarters is located in Williams Tower in Houston, Texas. Wikipedia
About Lyondellbasell Industries N.v
CEOPeter Vanacker
Employees19 k
FoundedDes. 2007
HeadquartersRotterdam, Suid-Holland, Nederland
SectorCommodity chemical
Websitelyondellbasell.com
Analyst ratings
Based on 12 analysts giving stock ratings to LYB in the past 3 months
Hold
Buy
4
Hold
6
Sell
2
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for LYB in the last 3 months.
Highest
Current USD 61,17
USD 80,00 (+30,78%)
Average
USD 66,73 (+9,09%)
Lowest
USD 56,00 (-8,45%)
Analyst
Recommendation
Action
Price target
Projected
Date
Arun Viswanathan
RBC Capital
Buy
Maintained
USD 68,00
+11,2%
10/13/2026
Michael Leithead
Barclays
Hold
Initiated
USD 66,00
+7,9%
10/12/2026
Aleksey Yefremov
Barclays
Hold
Initiated
USD 66,00
+7,9%
10/12/2026
Duffy Fischer
Goldman Sachs
Sell
Maintained
USD 63,00
+3%
10/12/2026
Abigail Eberts
Wells Fargo
Buy
Maintained
USD 70,00
+14,4%
10/07/2026
John McNulty
BMO Capital
Hold
Maintained
USD 68,00
+11,2%
10/05/2026
Patrick Cunningham
Citi
Hold
Downgraded
USD 63,00
+3%
10/01/2026
Joshua Spector
UBS
Hold
Reiterated
USD 62,00
+1,4%
09/25/2026
Unknown Analyst
KeyBanc
Hold
Initiated
-
-
09/11/2026
Salvator Tiano
KeyBanc
Hold
Initiated
-
-
09/11/2026
Vincent Andrews
Morgan Stanley
Buy
Maintained
USD 72,00
+17,7%
08/04/2026
Matthew DeYoe
Bank of America Securities
Sell
Reiterated
USD 56,00
-8,5%
08/03/2026
John Roberts CFA
Mizuho Securities
Hold
Maintained
USD 66,00
+7,9%
08/03/2026
Jeffrey Zekauskas
J.P. Morgan
Buy
Upgraded
USD 80,00
+30,8%
08/03/2026
Michael Sison
Wells Fargo
Buy
Reiterated
USD 70,00
+14,4%
07/02/2026
Hassan Ahmed
Alembic Global
Buy
Reiterated
USD 83,00
+35,7%
07/02/2026
Unknown Analyst
Argus Research
Hold
Maintained
-
-
05/18/2026
David Begleiter
Deutsche Bank
Hold
Reiterated
USD 80,00
+30,8%
05/05/2026
Eric Boyes
Evercore ISI
Hold
Maintained
USD 70,00
+14,4%
05/04/2026
Laurence Alexander
Jefferies
Hold
Maintained
USD 70,00
+14,4%
03/10/2026
Frank Mitsch
Fermium Research
Buy
Upgraded
USD 74,00
+21%
03/09/2026
Kevin McCarthy
Vertical Research
Buy
Upgraded
USD 75,00
+22,6%
03/09/2026
Last report
31 Jul. 2026
Fiscal period
Q2 2026
USD 4,30 / USD 3,42
+25,60%beat
Revenue / Est. (USD)
9,18 mjd / 9,29 mjd
-1,17%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
7,73 mjd
7,09 mjd
7,20 mjd
9,18 mjd
Cost of goods sold
6,82 mjd
6,75 mjd
6,50 mjd
7,11 mjd
Cost of revenue
6,82 mjd
6,75 mjd
6,50 mjd
7,11 mjd
Research and development expenses
34,00 m
33,00 m
36,00 m
34,00 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
405,00 m
376,00 m
415,00 m
390,00 m
Operating expense
439,00 m
409,00 m
451,00 m
424,00 m
Total operating expenses
7,26 mjd
7,16 mjd
6,95 mjd
7,53 mjd
Operating income
467,00 m
-65,00 m
250,00 m
1,64 mjd
Other non operating income
4,00 m
-21,00 m
10,00 m
61,00 m
EBT including unusual items
-858,00 m
-144,00 m
135,00 m
807,00 m
EBT excluding unusual items
350,00 m
-118,00 m
150,00 m
1,65 mjd
Income tax expense
-27,00 m
-8,00 m
-2,00 m
236,00 m
Effective tax rate
3,15%
5,56%
-1,48%
29,24%
Other operating expenses
-
-
-
-
Net income
-892,00 m
-142,00 m
123,00 m
558,00 m
Net profit margin
-11,54%
-2,00%
1,71%
6,08%
Earnings per share
1,01
-0,26
0,49
4,30
Interest and investment income
21,00 m
25,00 m
31,00 m
24,00 m
Interest expense
-132,00 m
-134,00 m
-140,00 m
-139,00 m
Net interest expenses
-111,00 m
-109,00 m
-109,00 m
-115,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
817,00 m
167,00 m
592,00 m
1,99 mjd
Gain or loss from assets sale
6,00 m
-112,00 m
-
734,00 m
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme